Table 3. Comparison of the mean BCVA between each group and baseline values.

BCVA (ETDRS letters)	Baseline evaluation	Following evaluation visit	P	Effect size, r
Naïve patients
Baseline-2wk (n=11)	53.18±18.519	59.27±15.84	0.313	0.053
Baseline-month 1 (n =10)	48.70±20.581	56.60±19.69	0.027	0.027
Baseline-month 2 (n=23)	50.52±17.508	60.91±11.53	0.004	0.541
Baseline-month 3 (n=8)	49.25±19.884	63.25±11.65	0.028	0.220
Baseline-month 4 (n=20)	60.60±10.065	54.80±12.66	0.020	0.778
Baseline-month 6 (n=18)	58.94±13.366	62.78±15.10	0.161	0.115
Non-naïve patients
Baseline-2wk (n=4)	47.00±16.971	42.50±10.61	0.317	0.5
Baseline-month 1 (n=3)	51.00±13.856	49.67±18.18	0.655	0.015
Baseline-month 2 (n=8)	39.13±18.209	43.50±21.06	0.041	1.388
Baseline-month 3 (n=4)	47.75±19.956	52.00±15.56	0.285	0.142
Baseline-month 4 (n=14)	57.00±18.385	63.50±19.09	0.140	0.544
Baseline-month 6 (n=9)	49.67±16.462	52.67±15.03	0.498	0.05

BCVA: Best corrected visual acuity; SD: Standard deviation.

mean±SD